4//SEC Filing
Glynn Craig 4
Accession 0001493152-21-030331
CIK 0001661053other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 6:25 PM ET
Size
7.4 KB
Accession
0001493152-21-030331
Insider Transaction Report
Form 4
Glynn Craig
Chief Financial Officer
Transactions
- Award
Stock Options
2021-11-30+125,925→ 125,925 totalExercise: $6.70Exp: 2031-11-30→ Common Stock (125,925 underlying) - Award
Common Stock
2021-11-30+50,000→ 50,000 total
Footnotes (2)
- [F1]The Reporting Person was granted 50,000 restricted stock units on November 30, 2021 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The restricted stock units are subject to milestone-based vesting as follows: (i) 50% upon SAVVE (Surgical Anti-reflux Venous Valve Endoprosthesis) endpoints being achieved, and (ii) 50% upon the Pre-Market Approval of the VenoValve.
- [F2]The common stock options were issued to the Reporting Person on November 30, 2021 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2024.
Documents
Issuer
enVVeno Medical Corp
CIK 0001661053
Entity typeother
Related Parties
1- filerCIK 0001809590
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 6:25 PM ET
- Size
- 7.4 KB